Dr Brian White
Brian is a Healthcare research analyst with over 30 years of experience working for global and regional investment banks. At Deutsche Bank and Cantor Fitzgerald, he was Managing Director and Head of Pharmaceutical and Biotechnology research. Brian writes what is widely regarded as industry-leading research on large and small-cap healthcare companies. He has been highly ranked by major external independent rating agencies, including Institutional Investor, Extel and Starmine. He played a leading role in numerous IPOs and fundraising transactions for European healthcare companies, conducting extensive investor education throughout the UK, Europe, the US and Asia.
Andrew has over 25 years of experience as a stockbroker working for various global and regional investment banks, including Deutsche Bank and Cantor Fitzgerald. He has a large network of investor contacts ranging from specialists to generalists across Europe and the US. Andrew played leading roles in IPOs and conducted multiple secondary placings, advising on marketing pitches through to deal completion. At Calvine, he is responsible for research distribution and investor introduction for client companies. Andrew is a qualified Chartered Accountant with an MBA.